Technological transformation continues to drive international demand for venture capital

There has been sustained optimism in and around venture and growth capital investment, not least in Europe. The pandemic has accelerated the need for technology and increased the demand for venture capital (VC) activity worldwide. Technological transformation has continued to advance and growth companies continue to need capital.

Many tech sectors, such as fintech “green” innovation and healthcare, and have a growing need for capital access – and VC funding will be critical in the race to carbon net zero. VC support offers an opportunity for growth and for shareholder and stakeholder alignment.

Market leader

Osborne Clarke's venture and growth capital practice is a market leader in technology, financial services, renewable energy and life sciences across Europe. Whether acting on fund establishment or investments across the corporate lifecycle, we support growth – no matter what is needed.

For companies and management teams, we advise on large venture and growth rounds, usually between £10m to £100m, handling 400-plus investment rounds a year. We also help with venture debt facilities, convertible loans and alternative finance, and advise on incentives, employment, share options, regulatory and IP for those looking to transform markets through technology.

For start-ups, we advise on earlier and smaller seed rounds offering support to more than 100 sub-£5 million investments a year, including with major university research institutions such as Imperial College, King’s College London, UCL, Oxford and Cambridge. We are always available like in-house lawyers – but without the cost of hiring internal expertise.

International know-how

Top-tier international funds and corporate investors on international venture and growth capital investments turn to us for our market knowledge and hands-on experience. Our venture funds formation practice supports our institutional client base, advising on VC with legal, regulatory and tax support.

And, with exits, we are there to help companies and investors get the best terms possible – whether a trade sale or initial public offering. This includes advice to numerous VC-backed companies on trade sales to global technology acquirers such as Cisco, Google, Apple, Facebook and Microsoft.


VC funding will be critical in the race to carbon net zero.




Osborne Clarke advises Taxfix on its USD 220 million Series D Funding Round, read more


Osborne Clarke advises Grover in USD 330 million Series C financing round, read more

Sequoia Capital, Thrive Capital and TCV

Osborne Clarke advised lead investors Sequoia Capital, Thrive Capital and TCV on Trade Republic's Series C financing round of over EUR 700 million


Osborne Clarke advises N26 in billion-dollar funding round with top investors, read more

Warburg Pincus and Hollyport Capital

Osborne Clarke advises Warburg Pincus and Hollyport Capital on Series D financing round of McMakler, read more


Osborne Clarke has advised DoorDash on USD 750 million Series B financing round of rapid delivery firm Flink SE, read more

Highland Europe

Advised Highland Europe on its series C $100 million investment in Plentific, read more.

DB Schenker

Osborne Clarke advises DB Schenker in Volocopter Series D financing round


Advised BGF on its lead investment in a £58m funding round in Elvie, read more.

Nexeon Limited

Acted for Nexeon Limited on $80m refinancing.


Osborne Clarke advises Taxdoo on Series A Financing Round, read more

Causeway Technologies

Advised Causeway Technologies on a £120 million investment from Five Arrows Principal Investments, read more.


Advised Accel and 14W as investors in $181M series F round led by Korelya in second-hand marketplace Wallapop.


Advised Barcelona-based HR SaaS developer Factorial in $80M series B finance round led by Tiger Global

Hadean Ventures and Sunstone Capital

Advised investors Hadean Ventures and Sunstone Capital on a €35m Series B investment in Step Pharma SAS, read more.

Highland Europe

Advised Highland Europe on a €35m fund raising and share deal for Snapshift.


We advised on the $350m exit to Vonage Inc, having acted for NVM on its previous equity financings, read more.


Advised MADE.COM on £40M equity funding round, read more.

Breath Therapeutics

Advised on the sale of Breath Therapeutics to Zambon, read more.

Highland Europe

We advised Highland Europe on three recent series B growth investments: EUR 25m in Camunda; £20m in Farewill and EUR 22m in Modulr.

Business Growth Fund

We advised BGF on its £6m investment in driverless car software developer Oxbotica (as part of a $47m round), read more.

Endeavour Vision

We advised the lead investor on the $30m series D investment in Lumeon – a leader in care pathway orchestration, read more.

Goldman Sachs

Advised Goldman Sachs on $22m Series A funding for DiffBlue and on the Series A funding investment in AI-specialist Eigen Technologies.

Koa Health

We advised the company on a EUR 30m series A round led by Wellington Partners and Ancora, read more.

Secure Code Warrior

Advised Secure Code Warrior on the closure of its $47.6M Series B round led by Goldman Sachs. Read more >

LAVA Therapeutics

We advised on the $83 million Series C financing led by Novo Ventures and Sanofi Ventures, read more.

Community Fibre

We advised the Company, the London Gigafast broadband provider, on a £50m funding round from RPMI and Amber Infrastructure, read more.


Advised on fund IV formation.

firstminute capital

We advised firstminute on its establishment and launch of its two venture funds, most recently firstminute capital II LP (target $125m)

Passion Capital

Advising Passion Capital on the launch of its third venture fund, Passion Capital III LP (£60m).


Advising PROfounders on its establishment and launch of its second fund (£60m)


Advising on the MMC Scale-up Fund and MMC Greater London Fund.